7Baggers
 BriaCell to Present Key Clinical Data at SABCS 2025  TipRanks Tue, 18 Nov 2025 13:19:59 GMT
 BriaCell to present updated cancer immunotherapy data at SABCS By Investing.com  Investing.com South Africa Tue, 18 Nov 2025 13:08:57 GMT
 BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025  Yahoo Finance Singapore Tue, 18 Nov 2025 12:30:00 GMT
 published on: 2025-11-18 03:04:25  newser.com Tue, 18 Nov 2025 09:04:25 GMT
 (bct) proactive strategies (bct:ca)  news.stocktradersdaily.com Mon, 17 Nov 2025 08:58:03 GMT
 (bct) trading performance and risk management (bct:ca)  news.stocktradersdaily.com Fri, 14 Nov 2025 11:36:49 GMT
 (bct) trading performance and risk management (bct:ca)  news.stocktradersdaily.com Tue, 11 Nov 2025 14:14:35 GMT
 briacell therapeutics closes $13.8m public offering  MSN Sat, 08 Nov 2025 03:41:25 GMT
 briacell presents anti-cancer activity of bria-ots at sitc 2025  TipRanks Fri, 07 Nov 2025 12:46:30 GMT
 (bct) stock evaluation report (bct:ca)  news.stocktradersdaily.com Wed, 05 Nov 2025 19:39:40 GMT

BriaCell Therapeutics Corp
(NASDAQ:BCTX) 

BCTX stock logo

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The ...

Founded: 2006
CEO: Bill Williams  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends